Want to join the conversation?
Biotechnology company $BIIB said it has appointed Michel Vounatsos as EVP and Chief Commercial Officer effective April 18, 2016. Mr. Vounatsos will oversee the development and execution of $BIIB's global commercial strategy and he will report to CEO George Scangos. Mr. Vounatsos comes to $BIIB from Merck where he held various leadership positions.
Any idea why some investors are happy about the disastrous $UA results??
Wow! GM killed it with earnings today! Did not expect this after $F gave the feeling it will eclipse the Chevy maker completely!
Oil rebound starting to show up in energy stocks. $XOM $CVX
I have a feeling "CLOUDy" days are ahead, with $AMZN leading the pack.
$AAL is giving pay hikes to its employees but investors are sulking.